Test Price
2,800 AED✅ Home Collection Available
IL2RG Gene Combined Immunodeficiency, X-Linked, Moderate – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين IL2RG لنقص المناعة المشترك المرتبط بالكروموسوم X، المعتدل في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary:
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
- This service strictly adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 for minors, and UAE PDPL data privacy standards.
ملخص تنفيذي: يضمن اختبار تسلسل الجيل التالي لجين IL2RG دقة تشخيصية تبلغ 99.9% عبر مختبرات معتمدة بمعيار الآيزو. تشمل الخدمة جمع العينة منزليًا بسلسلة تبريد متطورة، واستشارة طبية ما بعد النتيجة. إمكانية التحقق من التغطية التأمينية عبر واتساب.
Overview
The IL2RG gene NGS test identifies pathogenic variants responsible for X‑linked combined immunodeficiency, moderate form, providing molecular confirmation for early intervention and family risk assessment. This analysis leverages the latest 2026 DHA‑endorsed sequencing protocols to deliver clinically actionable results within weeks.
| Feature | Our Test: IL2RG NGS | Closest Alternative: Single‑Gene Sanger Sequencing |
|---|---|---|
| Precision | >99.9% analytical sensitivity for entire coding region & splice sites | 90–95% for targeted variants only |
| Method | Next‑Generation Sequencing (NGS) | Sanger Sequencing |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
| ICD‑10‑CM Codes | D81.2 – Severe combined immunodeficiency with low/normal B‑cells; Z00.5 – Encounter for genetic testing; D81.9 – Combined immunodeficiency, unspecified | |
| LOINC | 82939‑0 – IL2RG gene mutations tested for by molecular genetics method | |
Physician Insight & Safety Protocol
Clinical Perspective from Dr. Prabhakar Reddy (DHA License: 61713011):
“As a specialist deeply involved in primary immunodeficiency care, I recognise the emotional weight a genetic testing decision carries. This NGS assay offers a definitive molecular diagnosis, but I always emphasise that results must be correlated with a full immunological work‑up and family history – no single test tells the whole story. Please consult with our clinical immunologist team to interpret findings within your unique health context.”
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Safety & Exclusion Criteria
- Exclusion Criteria: Not appropriate for patients with an active severe infection requiring urgent medical intervention, or for individuals who have undergone a bone marrow transplant within the last 6 months (donor DNA may interfere with sequencing results).
- Emergency Red Flags: If you or the patient develop high fever (≥38.5 °C), respiratory distress, or worsening signs of immune deficiency while awaiting results, seek emergency care immediately. Inform the emergency physician about the pending IL2RG test.
- Clinical history and a pre‑test genetic counselling session are mandatory to ensure correct interpretation of the pedigree.
Patient FAQ & Clinical Guidance
What is the IL2RG gene test, and who should consider it?
This next‑generation sequencing test provides a comprehensive analysis of the IL2RG gene to identify mutations linked to X‑linked combined immunodeficiency, moderate form, which is crucial for early diagnosis and family planning.
هذا الاختبار بتسلسل الجيل التالي يقدم تحليلًا شاملاً لجين IL2RG للكشف عن الطفرات المرتبطة بنقص المناعة المشترك المرتبط بالكروموسوم X، وهو ضروري للتشخيص المبكر وتخطيط الأسرة.
How is the sample collected for this?
A simple blood draw, one drop of blood on an FTA card, or previously extracted DNA is all that’s required; our VIP phlebotomy team will collect the sample at your home through a hospital‑grade cold‑chain protocol.
كل ما هو مطلوب هو سحب دم بسيط، أو قطرة دم واحدة على بطاقة FTA، أو حمض نووي مستخلص، ويمكن لفريق سحب الدم المتنقل جمع العينة في منزلك وفقًا لبروتوكول سلسلة التبريد المعتمد.
What is the turnaround time and what does the report include?
Results are delivered within 3 to 4 weeks, including a detailed interpretation by clinical geneticists and actionable recommendations for follow‑up with an immunologist.
تظهر النتائج في غضون 3 إلى 4 أسابيع، وتتضمن تفسيرًا مفصلًا من قبل علماء الوراثة السريرية وتوصيات للمتابعة مع أخصائي المناعة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians